1. bookVolume 25 (2020): Issue 1-2 (December 2020)
Journal Details
License
Format
Journal
First Published
17 Jan 2013
Publication timeframe
2 times per year
Languages
English
access type Open Access

Study on in vitro Toxicity of Biometal(II) Monensinates Against Rat Zajdela Liver Tumour

Published Online: 29 Jan 2021
Page range: 125 - 132
Journal Details
License
Format
Journal
First Published
17 Jan 2013
Publication timeframe
2 times per year
Languages
English
Abstract

The ability of Monensic acid A (MonH∙H2O) and its neutral metal complexes [M(Mon)2(H2O)2]with ions of Mg2+, Ca2+, Mn2+, Co2+, Ni2+ and Zn2+ to decrease viability and proliferation of primary cell cultures, originating from a chemically induced transplantable liver tumour of Zajdela in rats, and bone marrow cells from the same tumour-bearers, was evaluated. Experimental data revealed that manganese(II) and nickel(II) complexes of Monensin A are relatively more selective against the tumour as compared to the healthy bone marrow cells.

Keywords

[l] Chapman HD, Barta JR, Blake D, Gruber A, Jenkins M, Smith NC, et al. Adv Parasitol. 2013;83:93-171. DOI: 10.1016/B978-0-12-407705-8.00002-1.Search in Google Scholar

[2] Chapman HD, Jeffers TK, Williams RB. Poultry Sci. 2010;89:1788-801. DOI: 10.3382/ps.2010-00931.Search in Google Scholar

[3] Anadón A, Martinez-Larrañaga MR, Castellano V. J Vet Pharmacology Therapeutics. 2009;32(S1):26-8. DOI: 10.1111/j.1365-2885.2009.01087.x.Search in Google Scholar

[4] Stefańska J, Stepień K, Huczyński A, Tyski S. Polish J Microbiol. 2015;64:273-8. DOI: 10.5604/01.3001.0009.2122.Search in Google Scholar

[5] Mimouni M, Khardli FZ, Warad I, Ahmad M, Mubarak MS, Sultana S, et al. J Mater Environ Sci. 2014;5(1):207-14. Available from: www.jmaterenvironsci.com/Document/vol5/vol5_N1/24-JMES-562-2014-Mimouni.pdf.Search in Google Scholar

[6] Rutkowski J, Brzezinski B. BioMed Res Int. 2013; art. 162513. DOI: 10.1155/2013/162513.Search in Google Scholar

[7] Huczyński A, Stefańska J, Piśmienny M, Brzezinski B. J Mol Struct. 2013;1034:198-206. DOI: 10.1016/j.molstruc.2012.09.007.Search in Google Scholar

[8] Huczyński A, Ratajczak-Sitarz M, Stefańska J, Katrusiak A, Brzezinski B, Bartl F. J Antbiot. 2011;64:249-56. DOI: 10.1038/ja.2010.167.Search in Google Scholar

[9] Łowicki D, Huczyński A, Stefańska J, Brzezinski B. Tetrahedron. 2011;67:1468-78. DOI: 10.1016/j.tet.2010.12.033.Search in Google Scholar

[10] Łowicki D, Huczyński A, Stefańska J, Brzezinski B. Eur J Med Chem. 2010;45:4050-7. DOI: 10.1016/j.ejmech.2010.05.064.Search in Google Scholar

[11] Łowicki D, Huczyński A, Stefańska J, Brzezinski B. Tetrahedron. 2009;65:7730-40. DOI: 10.1016/j.tet.2009.06.077.Search in Google Scholar

[12] Nelson ML, Grier MC, Barbaro SE, Ismail MY. Anti-Infect Agents Med Chem. 2009;8:3-16. DOI: 10.2174/187152109787047779.Search in Google Scholar

[13] Hansen M, Krogh KA, Brandt A, Christensen JH, Halling-Sørensen B. Environ Pollut. 2009;157:474-80. DOI: 10.1016/j.envpol.2008.09.022.Search in Google Scholar

[14] Kevin II DA, Meujo DAF, Hamann MT. Expert Opin Drug Discov. 2009;4:109-46. DOI: 10.1517/17460440802661443.Search in Google Scholar

[15] Huczyński A, Stefańska J, Przybylski P, Brzezinski B, Bartl F. Bioorg Med Chem Lett. 2008;18:2585-9. DOI: 10.1016/j.bmcl.2008.03.038.Search in Google Scholar

[16] Park WH, Seol JG, Kim ES, Kang WK, Im YH, Jung CW, et al. Brit J Haem. 2002;119:400-7. DOI: 10.1046/j.1365-2141.2002.03834.x.Search in Google Scholar

[17] Park WH, Jung CW, Park JO, Kim K, Kim WS, Im YH, et al. Int J Oncol. 2003;22:855-60. DOI: 10.3892/ijo.22.4.855.Search in Google Scholar

[18] Park WH, Kim ES, Jung CW, Kim BK, Lee YY. Int J Oncol. 2003;22:377-82. DOI: 10.3892/ijo.22.2.377.Search in Google Scholar

[19] Park WH, Kim ES, Kim BK, Lee YY. Int J Oncol. 2003;23:197-204. DOI: 10.3892/ijo.23.1.197.Search in Google Scholar

[20] Ketola K, Vainio P, Fey V, Kallioniemi O, Iljin K. Mol Cancer Therapeutics. 2010;9:3175-85. DOI: 10.1158/1535-7163.MCT-10-0368.Search in Google Scholar

[21] Ketola K, Vuoristo A, Orešič M, Kallioniemi O, Iljin K. Monensin Induced Oxidative Stress Reduces Prostate Cancer Cell Migration and Cancer Stem Cell Population. Chapter 23 In: Oxidative Stress and Diseases. Lushchak V, editor. InTech; 2012: 521-40. ISBN: 9789535105527. DOI: 10.5772/34713.Search in Google Scholar

[22] Kim SH, Kim KY, Yu SN, Park SG, Yu HS, Seo YK, et al. Anticancer Res. 2016;36:5835-43. DOI: 10.21873/anticanres.11168.Search in Google Scholar

[23] Tyagi N, Ghosh PC. Eur J Pharm Sci. 2011;43:343-53. DOI: 10.1016/j.ejps.2011.05.010.Search in Google Scholar

[24] Tyagi N, Rathore SS, Ghosh PC. Drug Deliv. 2011;18:394-404. DOI: 10.3109/10717544.2011.567309.Search in Google Scholar

[25] Tyagi N, Rathore SS, Ghosh PC. Indian J Pharm Sci. 2013;75:16-22. DOI: 10.4103/0250-474X.113533.Search in Google Scholar

[26] Yoon MJ, Kang YJ, Kim IY, Kim EH, Lee JA, Lim JH, et al. Carcinogenesis. 2013;34:1918-28. DOI: 10.1093/carcin/bgt137.Search in Google Scholar

[27] Choi HS, Jeong EH, Lee TG, Kim SY, Kim HR, Kim CH. Tuberc Respir Dis. 2013;75:9-17. DOI: 10.4046/trd.2013.75.1.9.Search in Google Scholar

[28] Tumova L, Pombinho AR, Vojtechova M, Stancikova J, Gradl D, Krausova M, et al. Mol Cancer Therapeutics. 2014;13:812-22. DOI: 10.1158/1535-7163.MCT-13-0625.Search in Google Scholar

[29] Deng Y, Zhang J, Wang Z, Yan Z, Qiao M, Ye J, et al. Sci Rep. 2015;5:17523. DOI: 10.1038/srep17523.Search in Google Scholar

[30] Verma SP, Das P, In Vitro Cell Develop Biol - Animal. 2018;54:736-42. DOI: 10.1007/s11626-018-0298-7.Search in Google Scholar

[31] Wang X, Wu H, Zhang Z, Ma C, Wu T, et al. Sci Rep. 2018;8:17914. DOI: 10.1038/s41598-018-36214-5.Search in Google Scholar

[32] Xin H, Li J, Zhang H, Li Y, Zeng S, Wang Z, et al. Peer J. 2019;7:e7354. DOI: 10.7717/peerj.7354.Search in Google Scholar

[33] Vanneste M, Huang Q, Li M, Moose D, Zhao L, Stamnes MA, et al. Sci Rep. 2019;9:1200. DOI: 10.1038/s41598-018-38019-y.Search in Google Scholar

[34] Pantcheva IN, Mitewa MI, Sheldrick WS, Oppel IM, Zhorova R, Dorkov P. Curr Drug Discov Technol. 2008;5:154-61. DOI: 10.2174/157016308784746247.Search in Google Scholar

[35] Pantcheva IN, Zhorova R, Mitewa M, Simova S, Mayer-Figge H, Sheldrick WS. BioMetals. 2010;23:59-70. DOI: 10.1007/s10534-009-9269-5.Search in Google Scholar

[36] Pantcheva IN, Ivanova J, Zhorova R, Mitewa M, Simova S, Mayer-Figge H, et al. Inorg Chim Acta. 2010;363:1879-86. DOI: 10.1016/j.ica.2010.02.009.Search in Google Scholar

[37] Alexandrova RI, Zhivkova T, Alexandrov M, Miloshev G, Georgieva M, Pantcheva IN, et al. Centr Eur J Chem. 2012;10:1464-74. DOI: 10.2478/s11532-012-0071-9.Search in Google Scholar

[38] Pantcheva IN, Alexandrova RI, Zhivkova T, Mitewa MI. Biotechn Biotechn Equipment. 2013;27:3703-8. DOI: 10.5504/BBEQ.2012.0088.Search in Google Scholar

[39] Markowska A, Kaysiewicz J, Markowska J, Huczyński A. Bioorg Med Chem Lett. 2019;29:1549-54. DOI: 10.1016/j.bmcl.2019.04.045.Search in Google Scholar

[40] Yusenko MV, Trentmann A, Andersson MK, Ghani LA, Jakobs A, Arteaga Paz MF, et al. Cancer Lett. 2020; pii: S0304-3835(20)30053-7. DOI: 10.1016/j.canlet.2020.01.039.Search in Google Scholar

[41] Bugde P, Biswas R, Merien F, Lu J, Liu DX, Chen M, et al. Expert Opin Therapeutic Targets. 2017;21:511-30. DOI: 10.1080/14728222.2017.1310841.Search in Google Scholar

[42] Heppner GH, Miller FR. Int Rev Cytol. 1998;177:1-56. DOI: 10.1016/S0074-7696(08)62230-5.Search in Google Scholar

[43] Park WH, Lee MS, Park K, Kim ES, Kim BK, Lee YY. Int J Cancer. 2002;101:235-42. DOI: 10.1002/ijc.10592.Search in Google Scholar

[44] Souza AC, Machado FS, Celes MRN, Faria G, Rocha LB, Silva JS, et al. J Vet Med A Physiol Pathol Clin Med. 2005;52:230-7. DOI: 10.1111/j.1439-0442.2005.00728.x.Search in Google Scholar

[45] Klejborowska G, Jędrzejczyk M, Stępczyńska N, Maj E, Wietrzyk J, Huczyński A. Chem Biol Drug Des. 2019;94:1859-64. DOI: 10.1111/cbdd.13581.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo